Clinical trial
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in…
NCT00202293 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00202293 |
|---|---|
| Title | Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features |
| Official title | Comparison of Combination Olanzapine and Lithium and Combination Chlorpromazine and Lithium in the Treatment of a First Manic Episode With Psychotic Features. |
| Lead sponsor | Melbourne Health, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Olanzapine, Lithium, Chlorpromazine |
| Enrollment | 83 |
| Start date | Oct 1, 2001 |
| Primary completion | Nov 1, 2015 |
| Completion | Nov 1, 2015 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 31, 2018 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: